Covered recipient · General Payments record
NICOL P MORSBY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,107.45
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $612.26 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $147.37 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $128.81 | 1 |
| E.R. Squibb & Sons, L.L.C. | $112.15 | 1 |
| Tempus AI, Inc | $96.53 | 4 |
| ABBVIE INC. | $70.89 | 3 |
| Merck Sharp & Dohme Corporation | $22.51 | 1 |
| Genentech USA, Inc. | $18.02 | 1 |
| Gilead Sciences, Inc. | $15.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.86 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107698244 | CMS |
| ABBVIE INC. | $22.22 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107698246 | CMS |
| ABBVIE INC. | $28.81 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107698248 | CMS |
| E.R. Squibb & Sons, L.L.C. | $112.15 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101411129 | CMS |
| Genentech USA, Inc. | $18.02 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133179155 | CMS |
| Gilead Sciences, Inc. | $15.98 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133647626 | CMS |
| Janssen Biotech, Inc. | $14.52 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078527738 | CMS |
| Janssen Biotech, Inc. | $24.32 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078524772 | CMS |
| Janssen Biotech, Inc. | $21.73 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078525101 | CMS |
| Janssen Biotech, Inc. | $86.80 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078523755 | CMS |
| Merck Sharp & Dohme LLC | $22.51 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141885067 | CMS |
| Novartis Pharmaceuticals Corporation | $128.81 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087045740 | CMS |
| Tempus AI, Inc | $24.32 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150184890 | CMS |
| Tempus AI, Inc | $24.27 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150184892 | CMS |
| Tempus AI, Inc | $23.90 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150184894 | CMS |
| Tempus AI, Inc | $24.04 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150184896 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.